Complement Inhibition

In this video, Michael Stewart, MD, professor and chairman of ophthalmology at the Mayo Clinic, highlights what he looks forward to in the future of geographic atrophy research, namely complement inhibition.

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Roger A. Goldberg, MD, MBA, discusses the role of multimodal imaging in geographic atrophy in the era of complement inhibitors.

CHICAGO — In this video, Joan W. Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses controversies surrounding the use of complement inhibitors for the treatment of geographic atrophy.

In this video, Barbara Blodi, MD, discusses advancements in complement inhibition treatments for geographic atrophy.

Carl D. Regillo, MD, spoke with Healio about the need for more geographic atrophy treatments.

Carl D. Regillo, MD, spoke with Healio about the use of complement blockers in geographic atrophy.

ORLANDO — Patients with catastrophic antiphospholipid syndrome appeared to have high rates of mutations in complement regulatory genes that could lead to uncontrolled complement activation and a more severe phenotype, according to study results presented during the plenary session of ASH Annual Meeting and Exposition.